In an ethidium bromide-induced demyelination rat model, quercetin treatment (50 mg/kg/day) prevented additional demyelination, improved remyelination, enhanced locomotor activity, inhibited lipid peroxidation, and preserved acetylcholinesterase (AChE) activity [257]. Here, ACHE is linked to Peripheral demyelination.